Mode
Text Size
Log in / Sign up

quadrivalent influenza vaccine

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of quadrivalent influenza vaccine

4 trials tracked of quadrivalent influenza vaccine: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 19 citations.

4Trials tracked
2Phase 3 & 4
0Recruiting
2With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 1 Other / NA 1
  1. Phase 3 A Study to Evaluate a Modified RNA Vaccine Against Influenza in Adults 18 Years of Age or Older Completed · 19 cited
  2. Phase 4 A Multicenter Study to Assess Response to Influenza Vaccine in Multiple Sclerosis Participants Treated With Ofatumumab Completed · 2 cited
  3. Phase 2 High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant Completed
  4. N/A This Study Intends to Describe the Characteristics of Patients Given the Pfizer-BioNTech Bivalent mRNA COVID-19 Vaccine and Any Commercially Available Influenza Vaccines at the Same Time Versus at Different Times. Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.